Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...